Living with Neuroendocrine Tumors
People with neuroendocrine tumors can lead meaningful, active, productive lives. Learn how you can make the most of every day.
The latest in NET News
New Clinical Trial Testing Chemotherapy After Surgery in High-Risk pNETs
A new phase II clinical trial is exploring the effects of two approved chemotherapy drugs administered after surgery to treat adult patients who have high-risk, well-differentiated pancreatic neuroendocrine tumors (pNETS).
New Clinical Trial Focuses on Targeted Alpha-Emitter Therapy of PRRT
A new phase II clinical trial is evaluating the safety and effectiveness of 212Pb-DOTAMTATE in patients who have somatostatin receptor-expressing neuroendocrine tumors but who have not received peptide receptor radionuclide therapy, or PPRT.
Earning Her Stripes as a Pink Zebra
By the time she was 40 years old, Alicia Gutierrez had earned her stripes as a pink zebra with diagnoses of breast cancer and pancreatic neuroendocrine cancer.
Attend a NET patient conference
Find support groups in your area
Check out patient advocacy groups
2Singh S, Granberg D, Wolin E, et al. Patient-reported burden of a neuroendocrine tumor (NET) diagnosis: results from the first global survey of patients with NETs. J Glob Oncol. 2016;2(1):43-53.